INTERNATIONAL PATENT: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT FILES APPLICATION FOR "METHOD FOR IDENTIFYING AND EMPLOYING TARGET SITE BLOCKING OLIGONUCLEOTIDES IN THE TREATMENT OF MEF2C HAPLOINSUFFICIENCY SYNDROME"

GENEVA, May 15 -- MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (135 Cannon, Suite 101LCharleston, South Carolina 29425) filed a patent application (PCT/US2024/054058) for "METHOD FOR IDENTIFYING AND EMPLOYING TARGET SITE BLOCKING OLIGONUCLEOTIDES IN THE TREATMENT OF MEF2C HAPLOINSUFFICIENCY SYNDROME" on Nov 01, 2024. With publication no. WO/2025/096897, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COWAN, Christopher (c/o MUSC Foundation for Research Development135 Cannon, Suite 101N, MSC 828Charleston, North Carolina 29425...